Dr. Aneel Paulus is a translational oncologist and entrepreneur with 15+ years experience in cancer biology and clinical oncology research. Aneel holds the position of Adjunct Associate Professor of Medicine at the Mayo Clinic School of Medicine and previously served as Director of Translational Research in Malignant B-cell Cancers and Co-Principal Investigator/Site Director for the B-cell cancer biorepository at the Jacksonville, Florida campus. He has published over 50 peer-reviewed scientific articles, contributed to several book chapters and presented at numerous premier conferences on his work in preclinical-to-early clinical drug development of immunotherapy and small-molecule immune-modulatory drugs. Aneel also holds an adjunct teaching faculty position as Associate Professor of Medicine at University of Florida, Shands Hospital. He currently serves as Co-Founder and Chief Scientific Officer at Alpha2 Pharmaceuticals (Mayo Clinic spinoff) and CEO of WestEastern Health. His consulting experience spans several Fortune 500 biopharma companies such as GSK, BMS, Astra-Zeneca, Jaansen, Takeda as well as others such as Natera, Ascentage, Affimed AB, Vivolux AB.